Details about Anirban Basu

Access statistics for papers by Anirban Basu.

Last updated 2012-05-03. Update your information in the RePEc Author Service.

Short-id: pba977

Working Papers

2011

1. Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
   See also Journal Article in Journal of Health Economics (2011)
2. Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality
   Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York
   Also in Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2011)

2010

3. The Impact of Comparative Effectiveness Research on Health and Health Care Spending
   NBER Working Papers, National Bureau of Economic Research, Inc
   See also Journal Article in Journal of Health Economics (2011)

2009

4. Estimating Lifetime or Episode-of-illness Costs
   Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York

2008

5. The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures
   NBER Working Papers, National Bureau of Economic Research, Inc
6. Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
   Also in Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2008) View citations (1)

2007

7. Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients
   Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York View citations (1)

2003

8. Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data
   NBER Technical Working Papers, National Bureau of Economic Research, Inc View citations (2)
   Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (2003) View citations (2)
   See also Journal Article in Journal of Health Economics (2005)

Journal Articles

2011

1. Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care
   Journal of Health Economics, 2011, 30, (3), 549-559 View citations (2)
   See also Working Paper (2011)
2. Erratum: Estimating lifetime or episode‐of‐illness costs under censoring
   Health Economics, 2011, 20, (1), 125-126
3. The impact of comparative effectiveness research on health and health care spending
   Journal of Health Economics, 2011, 30, (4), 695-706 View citations (5)
   See also Working Paper (2010)

2010

4. Estimating lifetime or episode‐of‐illness costs under censoring
   Health Economics, 2010, 19, (9), 1010-1028
5. The Economics of Comparative Effectiveness Studies: Societal and Private Perspectives and their Implications for Prioritizing Public Investments in Comparative Effectiveness Research
   PharmacoEconomics, 2010, 28, (10), 843-853 View citations (2)

2009

6. A linear index for predicting joint health-states utilities from single health-states utilities
   Health Economics, 2009, 18, (4), 403-419

2008

7. Social costs of robbery and the cost-effectiveness of substance abuse treatment
   Health Economics, 2008, 17, (8), 927-946 View citations (5)
8. Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
   Journal of Health Economics, 2008, 27, (3), 531-543 View citations (39)

2007

9. Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients
   Health Economics, 2007, 16, (11), 1133-1157 View citations (22)

2006

10. Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity
    Health Economics, 2006, 15, (10), 1091-1107 View citations (4)

2005

11. Extended generalized linear models: Simultaneous estimation of flexible link and variance functions
    Stata Journal, 2005, 5, (4), 501-516
12. Generalized modeling approaches to risk adjustment of skewed outcomes data
    Journal of Health Economics, 2005, 24, (3), 465-488 View citations (37)
    See also Working Paper (2003)
13. Implications of spillover effects within the family for medical cost-effectiveness analysis
    Journal of Health Economics, 2005, 24, (4), 751-773 View citations (8)

2004

14. Comparing alternative models: log vs Cox proportional hazard?
    Health Economics, 2004, 13, (8), 749-765 View citations (14)

2002

15. Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients?
    RAND Journal of Economics, 2002, 33, (3), 447-468 View citations (10)